Literature DB >> 16189623

Genetic studies of 20 Japanese families of dystrophic epidermolysis bullosa.

Daisuke Sawamura1, Maki Goto2, Kana Yasukawa2, Kazuko Sato-Matsumura2, Hideki Nakamura2, Kei Ito2, Hiroyuki Nakamura2, Yuki Tomita2, Hiroshi Shimizu2.   

Abstract

Dystrophic EB (DEB) is clinically characterized by mucocutaneous blistering in response to minor trauma, followed by scarring and nail dystrophy, and is caused by mutations in the COL7A1 gene encoding type VII collagen. DEB is inherited in either an autosomal dominant (DDEB) or recessive (RDEB) fashion. DDEB basically results from a glycine substitution mutation within the collagenous domain on one COL7A1 allele, while a combination of mutations such as premature stop codon, missense, and splice-site mutations on both alleles causes RDEB. In this study, mutation analysis was performed in 20 distinct Japanese DEB families (16 RDEB and four DDEB). The result demonstrated 30 pathogenic COL7A1 mutations with 16 novel mutations, which included four missense, five nonsense, one deletion, two insertion, one indel, and three splice-site mutations. We confirmed that Japanese COL7A1 mutations were basically family specific, although three mutations, 5818delC, 6573 + 1G > C, and E2857X, were recurrent based on previous reports. Furthermore, the Q2827X mutation found in two unrelated families would be regarded as a candidate recurrent Japanese COL7A1 mutation. The study furthers our understanding of both the clinical and allelic heterogeneity displayed in Japanese DEB patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189623     DOI: 10.1007/s10038-005-0290-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  20 in total

Review 1.  Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa.

Authors:  J D Fine; R A Eady; E A Bauer; R A Briggaman; L Bruckner-Tuderman; A Christiano; A Heagerty; H Hintner; M F Jonkman; J McGrath; J McGuire; A Moshell; H Shimizu; G Tadini; J Uitto
Journal:  J Am Acad Dermatol       Date:  2000-06       Impact factor: 11.527

2.  Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in 2 families with dystrophic epidermolysis bullosa.

Authors:  Kazuko C Sato-Matsumura; Kana Yasukawa; Yuki Tomita; Hiroshi Shimizu
Journal:  Arch Dermatol       Date:  2002-02

3.  Novel glycine substitution mutations in COL7A1 reveal that the Pasini and Cockayne-Touraine variants of dominant dystrophic epidermolysis bullosa are allelic.

Authors:  A Kon; K Nomura; L Pulkkinen; D Sawamura; I Hashimoto; J Uitto
Journal:  J Invest Dermatol       Date:  1997-11       Impact factor: 8.551

4.  Genotype-phenotype correlation in italian patients with dystrophic epidermolysis bullosa.

Authors:  Rita Gardella; Daniele Castiglia; Patrizia Posteraro; Silvia Bernardini; Nicoletta Zoppi; Mauro Paradisi; Gianluca Tadini; Sergio Barlati; John A McGrath; Giovanna Zambruno; Marina Colombi
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

5.  Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1).

Authors:  A Järvikallio; L Pulkkinen; J Uitto
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

6.  Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage of mismatch, and conformation sensitive gel electrophoresis.

Authors:  N V Whittock; G H Ashton; R Mohammedi; J E Mellerio; C G Mathew; S J Abbs; R A Eady; J A McGrath
Journal:  J Invest Dermatol       Date:  1999-10       Impact factor: 8.551

7.  Strategy for identification of sequence variants in COL7A1 and a novel 2-bp deletion mutation in recessive dystrophic epidermolysis bullosa.

Authors:  A M Christiano; G G Hoffman; X Zhang; Y Xu; Y Tamai; D S Greenspan; J Uitto
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

8.  The molecular basis of dystrophic epidermolysis bullosa in Mexico.

Authors:  J C Salas-Alanis; M Amaya-Guerra; J A McGrath
Journal:  Int J Dermatol       Date:  2000-06       Impact factor: 2.736

9.  Novel and de novo glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling.

Authors:  F Rouan; L Pulkkinen; M F Jonkman; J W Bauer; P B Cserhalmi-Friedman; A M Christiano; J Uitto
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

10.  A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa.

Authors:  A M Christiano; A Morricone; M Paradisi; C Angelo; C Mazzanti; R Cavalieri; J Uitto
Journal:  J Invest Dermatol       Date:  1995-03       Impact factor: 8.551

View more
  3 in total

1.  COL7A1 mutation G2037E causes epidermal retention of type VII collagen.

Authors:  Daisuke Sawamura; Kazuko Sato-Matsumura; Satoko Shibata; Akari Tashiro; Masutaka Furue; Maki Goto; Kaori Sakai; Masashi Akiyama; Hideki Nakamura; Hiroshi Shimizu
Journal:  J Hum Genet       Date:  2006-03-24       Impact factor: 3.172

2.  A novel COL7A1 gene mutation in an Iranian individual suffering dystrophic epidermolysis bullosa.

Authors:  Hamid Galehdari; Gholamreza Mohammadian; Somayeh Azmoon; Bahaoddin Salehi; Mohammad Pedram
Journal:  J Mol Diagn       Date:  2010-02-26       Impact factor: 5.568

3.  Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.

Authors:  Kei Ito; Daisuke Sawamura; Maki Goto; Hideki Nakamura; Wataru Nishie; Kaori Sakai; Ken Natsuga; Satoru Shinkuma; Akihiko Shibaki; Jouni Uitto; Christopher P Denton; Osamu Nakajima; Masashi Akiyama; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.